NL-OMON52168招募中不适用
CoLab-score and viability PCR for SARS-CoV-2: routine blood test algorithm proven by elimination of viable SARS-CoV-2 to identify patients in order to facilitate discharge and/or de-isolation - CoLaIC
Zuyderland Medisch Centrum0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •- All patients admitted to the ICU /dept. of Lung diseases of the hospital
- •with COVID-19 related
- •complaints.
- •- Patients were required to have data on clinical chemistry and hematological
- •parameters to
- •calculate the CoLab-score.
排除标准
- •- Patients <18 years
- •- Patients with a known hematological malignancy
- •- Next to this, blood samples with:
- •o a deep anemia at the time of presentation to the ICU/nursing ward (Hb < 5.5
- •mmol/L of ery's <2.9*10^12/L))
- •o extreme laboratory values (>10* standard deviation (SD)) in one or more of
- •the Colab-values)
- •o hemolytic blood samples
研究者
相似试验
尚未招募
不适用
Pooled testing for COVIDCTRI/2020/06/026005ational Centre for Biological Sciences
尚未招募
不适用
COVID-19/ SARS-CoV-2 feces-PCR diagnosticsCOVID-19viral infection10047438NL-OMON49537Wetenschapsbureau30
已完成
不适用
Evaluation of SARS-CoV2-specific serum parameters in blood samples of SARS-CoV2-seronegative healthy volunteers, hospitalized SARS-CoV2-patients with acute disease and recovered SARS-CoV2-patients with asymptomatic/mild/severe disease.U07.1COVID-19, virus identifiedDRKS00023877Heidelberg ImmunoTherapeutics GmbH113
已完成
不适用
Evaluation of SARS-CoV2-specific serum parameters in blood samples of hospitalized COVID-19 patients with acute disease and recovered COVID-19 patients with asymptomatic disease (HTXCOV-01K)07.1DRKS00028158Heidelberg ImmunoTherapeutics GmbH16
招募中
不适用
Evaluation of SARS-CoV-2-specific Serum parameter in Blood of Patients with present post COVID (VANCOV-01)U09.9Post COVID-19 condition, unspecifiedDRKS00032918VANUDIS GmbH60